お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:世界の鬱病治療薬市場:薬剤タイプ別、流通チャネル別、地域別 - 世界の動向と予測
市場調査レポート
商品コード
629603

世界の鬱病治療薬市場:薬剤タイプ別、流通チャネル別、地域別 - 世界の動向と予測

Depression Therapeutics Market, by Drug Type, Distribution Channel, and Region - Global Trends, and Forecast till 2025

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 171 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.93円
世界の鬱病治療薬市場:薬剤タイプ別、流通チャネル別、地域別 - 世界の動向と予測
出版日: 2018年02月14日
発行: Coherent Market Insights
ページ情報: 英文 171 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の鬱病治療薬市場について調査し、市場の概要と薬剤タイプ別、流通チャネル別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 調査目的と仮定

第2章 市場概要

第3章 市場動向、法規制、動向分析

  • 市場動向
    • 促進因子
    • 阻害因子
    • 市場の機会
  • 影響分析
  • 主なハイライト
  • PEST分析
  • ポーターズファイブフォース分析
  • パイプライン分析

第4章 薬剤タイプ別

  • イントロダクション
  • 選択的セロトニン再摂取阻害剤
  • 選択的ノルエピネフリン再摂取阻害剤
  • その他

第5章 流通チャネル別

  • イントロダクション
  • 院内薬局
  • オンライン薬局
  • 小売薬局

第6章 地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • アフリカ
  • 中東

第7章 競合環境

  • ヒートマップ分析
  • 企業プロファイル

第8章 セクション

目次

Antidepressants are prescribed in serious to mild mental health conditions such as major depression and anxiety. Antidepressant drug category is highly lucrative due to low availability of alternative drug therapies for treatment of such disorders. Drug manufacturers are increasingly advancing the antidepressant drug category by introducing innovative therapies such as selective serotonin reuptake inhibitors (SSRIs) and selective norepinephrine reuptake inhibitors (SNRIs). Depression is one of the most common mental disorders, which are primarily treated by antidepressants. According to National Health Service Digital (NHS Digital), UK, antidepressant medication prescriptions observed the largest increase in 2016.

Market Dynamics

The global depression therapeutics market is driven by factors such as absence of alternative therapies and high presence of generic drug manufacturers in the market. Increasing number of major drugs are losing patent protection due to which increasing number of generic manufacturers are developing product variations, this in turn is boosting the growth of the market. Proven effectiveness of these medications in improving medical outcomes and increasing prevalence of disorders such as depression are fueling growth of the market. However, life threatening side effects associated with these medications as indicated by the black box warning on the packaging, as well as lack of research and development by major players are expected to hinder growth of the depression therapeutics market.

Key features of the study:

This report provides in-depth analysis of the global depression therapeutics market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global depression therapeutics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies

Key companies covered as a part of this study include Pfizer, Inc., Eli Lilly and Company, AstraZeneca Plc, Allergan Plc, GlaxoSmithKline Plc, Intellipharmaceutics International, Inc., Takeda Pharmaceutical Company Limited, H.Lundbeck A/S, Otsuka Holdings Co.,Ltd., Apotex, Inc., Shionogi & Co. Ltd., Zhejiang Hua Hai Pharmaceutical Co., Ltd, and Chengdu Kanghong Pharmaceutical Group Co.,Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics

The global depression therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global depression therapeutics market

Detailed Segmentation:

  • Global Depression Therapeutics Market, By Drug Type:
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Selective Norepinephrine Reuptake Inhibitors (SNRIs)
  • Others
  • Global Depression Therapeutics Market, By Distribution Channel:
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Global Depression Therapeutics Market, By Geography:
  • North America
  • By Drug Type
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Selective Norepinephrine Reuptake Inhibitors (SNRIs)
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • By Country:
  • U.S.
  • Canada
  • Mexico
  • Europe
  • By Drug Type
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Selective Norepinephrine Reuptake Inhibitors (SNRIs)
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Drug Type
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Selective Norepinephrine Reuptake Inhibitors (SNRIs)
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • By Country:
  • China
  • India
  • Japan
  • Southeast Asia
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • South America
  • By Drug Type
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Selective Norepinephrine Reuptake Inhibitors (SNRIs)
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • By Country:
  • Brazil
  • Argentina
  • Colombia
  • Rest of South America
  • Middle East & Africa
  • By Drug Type
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Selective Norepinephrine Reuptake Inhibitors (SNRIs)
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • By Country:
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of Middle East & Africa
  • Company Profiles
  • Pfizer, Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Eily Lilly, and Company
  • AstraZeneca Plc
  • Allergan Plc
  • GlaxoSmithKline Plc
  • Intellipharmaceutics International, Inc.
  • Takeda Pharmaceutical Company Limited
  • Lundbeck A/S
  • Otsuka Holdings Co. Ltd.
  • Apotex, Inc.
  • Shionogi & Co. Ltd.
  • Zhejiang Hua Hai Pharmaceutical Co., Ltd
  • Chengdu Kanghong Pharmaceutical Group Co. Ltd.
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Type
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • PEST Analysis
  • PORTER's Five Forces Analysis
  • Pipeline Analysis

4. Global Depression Therapeutics Market, By Drug Type, 2017-2025, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2017-2025
    • Segment Trends
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
  • Selective Norepinephrine Reuptake Inhibitors (SNRIs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)

5. Global Depression Therapeutics Market, By Distribution Channel, 2017-2025, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2017-2025
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)

6. Global Depression Therapeutics Market, By Regions, 2017-2025, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2025
  • North America
    • Market Size and Forecast, By Drug Type, 2017-2025, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017-2025, (US$ Mn)
    • Market Size and Forecast, By Country, 2017-2025, (US$ Mn)
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Market Size and Forecast, By Drug Type, 2017-2025, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017-2025, (US$ Mn)
    • Market Size and Forecast, By Country, 2017-2025, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Drug Type, 2017-2025, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017-2025, (US$ Mn)
    • Market Size and Forecast, By Country, 2017-2025, (US$ Mn)
    • China
    • India
    • Japan
    • Southeast Asia
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Market Size and Forecast, By Drug Type, 2017-2025, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017-2025, (US$ Mn)
    • Market Size and Forecast, By Country, 2017-2025, (US$ Mn)
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • Middle East & Africa
    • Market Size and Forecast, By Drug Type, 2017-2025, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of Middle East & Africa

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Pfizer, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Eily, Lilly, and Company
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • AstraZeneca, Plc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Allergan Plc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • GlaxoSmithKline Plc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Intellipharmaceutics International, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Takeda Pharmaceutical Company Limited
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • H.Lundbeck A/S
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Otsuka Holdings Co. Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Apotex, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Shionogi & Co. Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Zhejiang Hua Hai Pharmaceutical Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Chengdu Kanghong Pharmaceutical Group Co. Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

8. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.